Chimin Health Management Co., Ltd. (SHA:603222)

Market Cap	3.68B -1.0%
Revenue (ttm)	668.04M -7.6%
Net Income	-257.87M
EPS	-0.48
Shares Out	513.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,816,778
Open	7.10
Previous Close	7.00
Day's Range	7.06 - 7.18
52-Week Range	6.72 - 15.10
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Chimin Health Management

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells in vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-pipe double-valve, single-pipe single-valve, and single-pipe double-valve soft bags; plastic bottles; and other packaging forms. It also offers injection puncture medical devices, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precisi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 1,890
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603222

Financial Performance

In 2025, Chimin Health Management's revenue was 685.96 million, a decrease of -11.57% compared to the previous year's 775.73 million. Losses were -245.58 million, 311.3% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error